Evidence map›Paper›PMID 33806855›Full record

ReviewInternational journal of molecular sciences2021

Genetics of Azoospermia.

Francesca Cioppi, Viktoria Rosta, Csilla Krausz

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 5 pooled it
22.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 5 syntheses or guidelines pooled it, 171 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Whole-Genome Sequencing Identifies Potentially Causative Variants inInternational journal of molecular sciences · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. bioRxiv : the preprint server for biology · 2026
    Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Francesca CioppiDepartment of Biochemical, Experimental and Clinical Sciences "Mario Serio", University of Florence, 50139 Florence, Italy.ORCID 0000-0002-7718-6347
Viktoria RostaDepartment of Biochemical, Experimental and Clinical Sciences "Mario Serio", University of Florence, 50139 Florence, Italy.
Csilla KrauszDepartment of Biochemical, Experimental and Clinical Sciences "Mario Serio", University of Florence, 50139 Florence, Italy.
University of Florence · IT

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca PRIN 2018
6 · The paper itself

Abstract

Azoospermia affects 1% of men, and it can be due to: (i) hypothalamic-pituitary dysfunction, (ii) primary quantitative spermatogenic disturbances, (iii) urogenital duct obstruction. Known genetic factors contribute to all these categories, and genetic testing is part of the routine diagnostic workup of azoospermic men. The diagnostic yield of genetic tests in azoospermia is different in the different etiological categories, with the highest in Congenital Bilateral Absence of Vas Deferens (90%) and the lowest in Non-Obstructive Azoospermia (NOA) due to primary testicular failure (~30%). Whole-Exome Sequencing allowed the discovery of an increasing number of monogenic defects of NOA with a current list of 38 candidate genes. These genes are of potential clinical relevance for future gene panel-based screening. We classified these genes according to the associated-testicular histology underlying the NOA phenotype. The validation and the discovery of novel NOA genes will radically improve patient management. Interestingly, approximately 37% of candidate genes are shared in human male and female gonadal failure, implying that genetic counselling should be extended also to female family members of NOA patients.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseAllelesAnimalsAzoospermiaBiomarkersChromosome DeletionChromosomes, Human, YExome SequencingFemaleGenetic TestingHumansMalePhenotypeSpermatogenesisBiomarkersazoospermiaCBAVDcongenital hypogonadotropic hypogonadismexomegeneticsinfertilityKlinefelter syndromeNGSNOAY chromosome microdeletions

Identifiers

PMID33806855
PMCPMC8004677
OpenAlexW3138764120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.